Author(s)

Tiéoulé Mamadou Traore^1,2*, Abdoul Kader Tapsoba^2,3, Kays Chaker^2,4, Amine Hermi^2,4, Kheireddine Mrad Dali^2,4, Mokhtar Bibi^2,4, Yassine Ouanes^2,4, Ahmed Sellami^2,4, Sami Ben Rhouma^2,4, Yassine Nouira^2,4

¹University of Ouahigouya, Ouahigouya, Burkina Faso.
²Department of Urology, La Rabta Hospital, Tunis, Tunisia.
³University of Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.
⁴Faculty of Medicine of Tunis, University Tunis Manar, Tunis, Tunisia.

Objectives: To clarify the clinical, histological and therapeutic features of prostatic tuberculosis. Methods: We conducted a single-centre retrospective descriptive study of all patients presenting with prostatic tuberculosis between January 2002 and December 2020. Patients who were lost to follow-up, could not be reached by telephone or whose records were not usable were excluded from this study. Results: 240 patients were treated for urogenital tuberculosis, including 13 for isolated prostatic tuberculosis. The average age of the patients was 75 years. None of our patients had a history of tuberculosis. The average of international prostate symptom score (IPSS) was 27. Lower urinary tract symptoms in the filling phase were predominant. The digital rectal examination was suspicious in only one patient. The mean preoperative PSA was 9.24 ng/ml. 46.15% of patients underwent transurethral resection of the prostate and 53.85% underwent ultrasound-guided prostate biopsy. Histological examination showed epithelioid gigantocellular granuloma with isolated caseous necrosis in 61.53% of patients and associated adenomyomatous hyperplasia in 38.47% of patients. Antituberculosis treatment was given for 6 months. The average of follow up was 15 months. All patients reported an improvement in clinical signs with a mean post operative IPSS score of 17 and a normalisation of PSA levels. Conclusion: Isolated prostatic tuberculosis is a rare entity, it can simulate a cancer. In front of the symptoms of the lower urinary tract, the clinicians must think of it especially in the developing countries where tuberculosis still prevails in an endemic state.

Prostatic Tuberculosis, Epithelioid Gigantocellular Granuloma, Antituberculosis Treatment

Traore, T. , Tapsoba, A. , Chaker, K. , Hermi, A. , Dali, K. , Bibi, M. , Ouanes, Y. , Sellami, A. , Rhouma, S. and Nouira, Y. (2022) Primary Prostatic Tuberculosis: A Rare Entity. Open Journal of Urology, 12, 129-135. doi: 10.4236/oju.2022.122013.